Allergic Diseases
📧 Sign up to get email alerts when something new happens for Allergic Diseases.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-03-22Clinical Trial Update: Comparative Study of Specific IgE Levels to Common Foods and Aeroallergens Measured by EUROIMMUN Allergy and ImmunoCap
A completed clinical trial comparing specific IgE levels to common foods and aeroallergens using EUROIMMUN Allergy and ImmunoCap assays.
-
CLINICAL_TRIALS trial_result · 2017-01-12Clinical Trial Update: Effect of Intranasal Anti-IgE Antibodies on IgE Production [NA]
A completed clinical trial from the Medical University of Vienna investigated intranasal anti-IgE antibodies and their effect on IgE product…
-
CLINICAL_TRIALS trial_result · 2016-10-27Clinical Trial Update: Growth, Risks of Allergy and Metabolic Syndrome in 6 Year Old Children Born Preterm Compared to Postdischarge Nutrition [NA]
A completed clinical trial update examining growth, allergy risk, and metabolic syndrome in six-year-old children born very preterm, compari…
-
CLINICAL_TRIALS trial_result · 2016-10-27Clinical Trial Update: Anisakis Blastocystis Cryptosporidium Fish Prevalence
A completed University Hospital Lille trial evaluated the prevalence of Anisakis, Blastocystis, and Cryptosporidium in fish, with notes rela…
-
CLINICAL_TRIALS trial_result · 2016-08-24Clinical Trial Update: Effect of Probiotics in Reducing Infections and Allergies in Young Children Starting Daycare [NA]
Completed clinical trial evaluating the effect of probiotics on infections and allergies in young children starting daycare.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-07-19Clinical Trial Update: First in Man Evaluation of Single and Multiple Doses of Oral ATX2417 [Phase 1]
First-in-human Phase 1 study evaluating single and multiple oral doses of ATX2417 has been completed. The trial was sponsored by Atopix Ther…
-
FDA approval · 2016-03-30FDA Approved: HYDROXYZINE HYDROCHLORIDE — Supplemental Application (American Regent, Inc.)
The FDA approved a supplemental application for hydroxyzine hydrochloride from American Regent, Inc., finalizing an update to the generic pr…
-
CLINICAL_TRIALS trial_result · 2014-06-10Clinical Trial Update: Single Ascending-dose Study of the Safety, Tolerability, and Pharmacokinetics of REGN1908-1909 in Allergic, Adult Subjects [Phase 1]
Phase 1 single ascending-dose study assessing safety, tolerability, and pharmacokinetics of REGN1908-1909 in allergic adult subjects has bee…
-
CLINICAL_TRIALS trial_result · 2014-03-20Clinical Trial Update: Primary Prevention of Allergic Disease in Early Child by Lactobacillus Reuteri [Phase 2]
Phase 2 trial evaluating whether Lactobacillus reuteri can prevent allergic diseases in early childhood; the study has completed.
-
CLINICAL_TRIALS trial_result · 2014-01-28Clinical Trial Update: Prevalence of Allergic Diseases and Atopy in Subjects With Coronary Artery Disease
A completed clinical trial examining how common allergic diseases and atopy are among people with coronary artery disease.
-
CLINICAL_TRIALS trial_result · 2014-01-10Clinical Trial Update: Influence of Probiotic VSL#3 Administration on Metabolic and Immunological Profile of the Milk of Breastfeeding Mothers [Phase 4]
Phase 4 trial evaluating the impact of the probiotic VSL#3 on the metabolic and immunological profile of breast milk in breastfeeding mother…
-
CLINICAL_TRIALS research · 2012-10-04Clinical Trial Update: Pre-, Peri- and Postnatal Programming and Origins of Disease: Early Targeting the Epidemics of Allergy and Overweight [NA]
Clinical trial update on pre-, peri-, and postnatal programming to tackle allergy and overweight, sponsored by the University of Turku.
-
CLINICAL_TRIALS trial_result · 2012-07-06Clinical Trial Update: The Effect of Xolair on Inhibiting Leukotriene and Cytokine (IL-4 and IL-13) Release From Blood Basophils [Phase 4]
A Phase 4 clinical trial evaluating whether Xolair (omalizumab) inhibits the release of leukotrienes and the cytokines IL-4 and IL-13 from b…
-
CLINICAL_TRIALS trial_result · 2012-06-27Clinical Trial Update: Tolerance of Cereals for Atopic Children [NA]
A Nestlé-sponsored clinical trial evaluating tolerance to cereals in atopic children with allergy was terminated.
-
CLINICAL_TRIALS research · 2012-03-05Clinical Trial Update: Can Supplementation With Lactobacillus Reuteri and Omega-3 Fatty Acids During Pregnancy and Lactation Reduce the Risk of Allergic Disease in Infancy? [NA]
Trial update on whether maternal supplementation with Lactobacillus reuteri and omega-3 fatty acids during pregnancy and lactation can lower…
-
CLINICAL_TRIALS trial_result · 2010-09-20Clinical Trial Update: Allergy and Ashthma in Children Who Were Fed Supplemented Infant Formula
A completed clinical trial evaluated allergy and asthma outcomes in children who were fed supplemented infant formula, sponsored by Mead Joh…
-
CLINICAL_TRIALS trial_result · 2009-07-23Clinical Trial Update: Air Cleaners for Children and Adolescents With Asthma and Dog Allergy [NA]
This clinical trial update notes the completion of a study evaluating air cleaners for children and adolescents with asthma and dog allergy.
-
CLINICAL_TRIALS research · 2009-05-14Clinical Trial Update: Use Cord Blood Single Nucleotide Polymorphism to Predict the Later Development of Atopy and Allergy
A clinical trial update examines whether cord blood single nucleotide polymorphisms can predict the later development of atopy and allergic …
-
CLINICAL_TRIALS trial_result · 2009-05-04Clinical Trial Update: Does Omega-3 Fatty Acid Supplementation in Pregnancy and During Lactation Protect the Child From Allergic Disease? [NA]
A clinical trial update investigating whether omega-3 fatty acid supplementation during pregnancy and lactation can reduce allergic diseases…
-
CLINICAL_TRIALS trial_result · 2008-08-18Clinical Trial Update: Safety Study of Anti-IgE Immunotherapy in Allergic Patients [Phase 2]
A Phase 2 safety trial of anti-IgE immunotherapy in allergic patients has completed.